| Bioactivity | Lilotomab (HH1) is a murine anti-CD37 monoclonal antibody. Lilotomab reduces clonogenic survival. Lilotomab shows anti-tumor activity[1]. |
| Invitro | Lilotomab (0-40 µg/mL; 12 days) 降低 DOHH2 和 Ramos 细胞的克隆形成存活率[1]。Lilotomab (40 µg/mL; 18 h) 诱导 DOHH2 细胞轻微凋亡[1]。 Apoptosis Analysis[1] Cell Line: |
| Name | Lilotomab |
| CAS | 1453362-55-4 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |